Schimke immuno-osseous dysplasia: case report and review of 25 patients by Saraiva, JM et al.
Schimke immuno-osseous dysplasia: case report
and review of 25 patients
Jorge M Saraiva, Alexandra Dinis, Cristina Resende, Emília Faria, Clara Gomes,
A Jorge Correia, Júlia Gil, Nicolau da Fonseca
Abstract
Immuno-osseous dysplasia is character-
ised by spondyloepiphyseal dysplasia,
lymphopenia with defective cellular im-
munity, and progressive renal disease. We
describe a patient with a severe form of
the disease, review the features of another
24 patients, and discuss the previous
classification. The diVerences between the
two groups are not striking, and although
similarities are greater between aVected
sibs, the same diagnosis of Schimke
immuno-osseous dysplasia should apply
to them all. The aetiology and physio-
pathology of this rare osteochondrodys-
plasia of presumed autosomal recessive
inheritance remain unknown.
(J Med Genet 1999;36:786–789)
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Immuno-osseous dysplasia is a rare autosomal
recessive osteochondrodysplasia (MIM
242900).1 It was first described in one patient
by Schimke et al2 and to our knowledge 23
other cases have been published with this pos-
sible diagnosis.3–15 It is characterised by
spondyloepiphyseal dysplasia, defective cellu-
lar immunity, and progressive renal disease.
We describe a Portuguese patient with
immuno-osseous dysplasia, review the previous
case reports and classification, and discuss the
relevance of additional findings and variants.
Case report
The proband is the third child of non-
consanguineous, Portuguese parents (mother
38, father 40 years old). Both parents and the
older brother, aged 9 years, have normal
stature and are healthy. A male twin of his
brother was stillborn of unknown cause. The
proband was born at 32 weeks of gestation by
caesarean section following ultrasound prena-
tal diagnosis of intrauterine growth retarda-
tion. Birth length (38 cm), weight (1020 g),
and head circumference (27.5 cm) were all less
than the 3rd centile.
He was referred at the age of 5 years because
of short stature and proteinuria. Herpes zoster
had been diagnosed at 2 years. He had short
stature with a short neck and trunk (fig 1) and
normal development. His length was 79 cm
(<5th centile), his weight was 10.42 kg (<5th
centile), and his OFC was 47 cm (5th centile).
He had a triangular face, a broad nasal bridge,
bulbous nasal tip, and multiple lentigines.
Blood pressure was normal (112/62 mm Hg).
The voice was normally pitched and the hair,
eyes, and teeth were normal. He had no ascites
or oedema.
Skeletal x rays showed an increased antero-
posterior skull diameter, a J shaped sella
turcica, small iliac wings, small ossification
centres of the capital femoral epiphyses (fig 2),
platyspondyly (fig 3), slightly short metacar-
pals, and carpal bone age delay. A previous
brain ultrasound scan had been described as
normal and abdominal ultrasound scan and
karyotype (46,XY) were normal.
He had increased urinary glycosaminogly-
cans (38 mg/mmol creatinine, mostly chon-
droitin sulphate) with normal chromatography
of both glycosaminoglycans and oligosaccha-
rides. Plasma and leucocyte enzymatic activi-
ties were normal.
Haematological studies showed haemo-
globin 14.2 g/l, platelet count 387 × 103/µl, 8.7
× 103/µl leucocytes with lymphopenia (absolute
count 1.14 x 103/µl). Immunoglobulins IgG,
IgM, IgA, IgE, IgG1, IgG3, and IgG4 serum lev-
els were normal, but the IgG2 subclass level was
decreased (<0.08g/dl). Circulating immuno-
Figure 1 The proband at 5 years of age with
disproportionate short stature, short trunk and neck,
triangular face, broad nasal bridge, bulbous nasal tip, and
multiple lentigines. (Photograph reproduced with
permission.)
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complexes (<0.42 µg/ml, normal range <5.0
µg/ml) were normal.
Peripheral blood lymphocytes (flow cyto-
metry) showed a decreased number of total
CD3 T cells (52%) owing to a markedly
decreased number of subpopulation helper
CD4+ T cells (13%) with a decreased
CD4/CD8 ratio (0.5%). The ãä T cell receptor
CD3+ cells were increased (15%, normal
range <7.5%). Activation molecules were
slightly expressed in T lymphocytes: 25% of
CD4+ lymphocytes were CD25+ and 18%
were HLADR+. Also 50% of CD8+ T cells
were HLADR+. The subpopulation of
memory T lymphocytes (CD45RO+CD4+)
was increased (69%) and CD45+CD4+ naive
lymphocytes were reduced (32%). Delayed
hypersensitivity skin test to tetanus, diphtheria,
tuberculin, streptococcus, candida, trichophy-
ton, and proteus antigens was negative. Proli-
ferative responses of T cells to the mitogens
phytohaemagglutinin (PHA), pokeweed, and
superantigen staphylococcus protein A were
slightly reduced and the addition of recom-
binant interleukin 2 only enhanced the PHA
induced proliferative response.
He had normal renal function and electro-
lytes, hypoalbuminaemia (30 g/l), and neph-
rotic proteinuria (80 mg/m2/h). A renal biopsy
was performed that showed focal segmental
glomerulosclerosis and a steroid therapy trial
was unsuccessful. The patient developed ana-
sarca and hypertension in the third week of
treatment that resolved with albumin per-
fusion, antihypertensive treatment, and pred-
nisone decrease.
Discussion
Immuno-osseous dysplasia is characterised by
spondyloepiphyseal dysplasia, cellular immune
defect, and progressive renal failure with neph-
rotic proteinuria. The combination of all these
features as previously described allows this
diagnosis in the child reported here.
The combination of abnormalities of the
immune and skeletal systems is also present in
other osteochondrodysplasias, such as
cartilage-hair hypoplasia, as well as progressive
renal disease and skeletal dysplasia which are
features of asphyxiating thoracic dysplasia, but
it has been claimed that the presence of the
immune, skeletal, and renal abnormalities is
specific to immuno-osseous dysplasia.6
The association of focal segmental glomeru-
losclerosis with spondyloepiphyseal dysplasia
has also been described in two patients without
mention of the diagnosis of immuno-osseous
dysplasia.8 These two patients, the one de-
scribed here, and the 22 case reports where this
diagnosis was quoted can be classified into two
diVerent groups as was previously suggested,11
a severe form and a more benign variant.
The features of the 17 patients with
intrauterine growth retardation and severe
growth failure since birth (group 1) and those
of the other group of eight patients (group 2)
are similar (table 1). They all are intellectually
normal.
In group 1, patients develop nephrotic
syndrome aged 34 8 11 13 14 to 14 years.8 Immu-
nosuppressive therapy has never been noted to
be beneficial, with the one exception of
cyclosporin that decreased the proteinuria in
one patient.5 If the patients do not die of severe
infection (one death from sepsis at the age of 5
years (case 28), another from bacterial pneu-
monia at the age of 5 years,6 another from sep-
sis at the age of 6 years2) or because of absence
of treatment of the renal failure (patients 1 and
2 died at the age of 8 years of renal failure,
patient 4 at 5 years of pulmonary embolism4),
they progress to end stage renal failure aged 5
Figure 2 Pelvic radiograph showing small iliac wings and
small ossification centres of the capital femoral epiphyses,
laterally placed, with mild hip subluxation.
Figure 3 Lateral spine radiograph showing platyspondyly
with markedly short and rounded vertebral bodies.
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(cases 1, 2, and 311) to 15 years (case 18) and
kidney transplantation is required.
Positron emission tomography showed per-
fusion defects of both cerebral and cerebellar
arteries in three transplanted patients with
transient ischaemic attacks (cases 1, 2, and 311)
and moyamoya phenomenon was described in
another three patients.14 15 One patient died at 8
years old from cerebrovascular disease (case
211). The others were alive at ages 313 to 15
years (case 18).
In group 2, nephrotic syndrome starts late, in
children aged 4 (case 54) to 12 years (case 212),
who are only then noted to have spondyloepi-
physeal dysplasia and cellular immune defi-
ciency (not mentioned in case 511 or case 112).
The course of the renal disease is similar but
partial remission of proteinuria has been
reported (case 511). Chronic renal failure
required dialysis or renal transplantation at ages
6 (case 54) to 22 years (case 212). One patient
died when he was 10 years old from cytomega-
lovirus pneumonia and encephalitis,10 and
another when he was 12 years old from acute
lung oedema while he was on haemodialysis
(case 112). The others are alive aged 9 (case 511
and case 54) to 23 years (case 212).
Autosomal recessive inheritance is usually
suggested for immuno-osseous dysplasia. Re-
viewing the family data in all the case reports
there is a single sib pair in group 1 (cases 1 and
24), two consanguineous couples,15 and a single
recurrence (case 24) in four children born after
the proband. Before the birth of the proband
there are reports of 11 pregnancies with four
stillbirths and seven healthy children. In group
2, there is one instance of a couple of first
cousins who had three aVected children.12 The
only child born after the proband was aVected
as well as one of the three older children.12 The
inheritance is therefore still not clear, but a
recurrence risk of 25% should be given to the
parents of children with immuno-osseous dys-
plasia.
The age of onset of the disease is similar
within families, for example, the sib pair with
prenatal onset4 and the three sibs with late
onset.12 However, from the above description of
the two variants, the diVerences are not striking
and the diagnosis of immuno-osseous dysplasia
should apply to them all, although to establish
the prognosis for a second aVected child one
should take into consideration the phenotype
of the proband.
The only description of chondro-osseous
pathology (case 24) showed decreased cellular-
ity of the resting cartilage, with irregular nests
of chondrocytes below the growth zone and
abnormal endochondral bone formation with
complete lack of columnisation.
The immunological study of the patient with
Schimke immuno-osseous dysplasia described
in this case report, performed while without
immunosuppressive therapy, showed recurrent
lymphopenia with persistent reduction of T
lymphocytes and defective function of cellular
immunity. The number and function of B and
NK cells were normal. In some cases hypogam-
maglobulinaemia was ascribed to persistent
proteinuria.9
The cellular immune deficiency is usually
described as recurrent lymphopenia and re-
duced stimulation to mitogens, often with fail-
ure to perform cytogenetic study of blood
specimens. There is previous evidence of a
decreased number of T cells4 6 7 9 12 with reduc-
tion in CD4+ T cells.4 7 10 12 The percentages of
activated and memory T lymphocytes were
increased and peripheral blood CD3+ T cells
expressed an abnormally high proportion of ãä
TCR and reduced áâ TCR (case 34). The
increase in peripheral blood immature ãä TCR
CD3+ T cells may reflect a defect in
intrathymic T cell diVerentiation or selection
pathways.4 The histological study of one
thymus (case 14) had the appearance seen in
other T cell immunodeficiencies.
The progressive renal disease is described as
an immune complex nephritis with proteinuria
which progresses to focal and segmental
glomerulosclerosis and chronic renal failure.
Histological and ultrastructural studies of the
kidney have been described both from biopsy
and at necropsy.
While there is only mild proteinuria, there is
mention of minimal change nephrotic
syndrome13 or of basement membranes of the
glomerular capillary loops covered by broad-
ened foot processes of podocytes enclosing
protein droplets with a slightly wide mesangial
matrix that contains immune deposits more
numerous and larger in the mesangial region
(case 14). This is similar to the description of a
mild increase in the mesangium in some of the
glomeruli and focal globular accumulation of
hyaline material in Bowman’s capsule.10
In the nephrotic syndrome, renal biopsies
were described as showing extensive eVace-
ment and fusion of podocyte processes, tubuli
with homogeneous material and moderate
interstitial fibrosis,6 increased mesangial matrix
with inconsistent proliferation of the endocap-
illary cells (case 112), or increased mesangial
matrix and cellularity in most glomeruli, many
with segmental or total hyalinisation, focal
tubular atrophy, and increased fibrous
interstitium.9 10 There is often only reference to
focal and segmental glomerulosclero-
sis.5 8 11 14 15
Table 1 Phenotypic features of 25 patients with Schimke immuno-osseous dysplasia. The
17 with the severe form are in group 1 (this case report) 2 4-8 11 13-15 and the eight with the
more benign variant in group 2 4 9-12
Feature Group 1 (17) Group 2 (8) All patients (25)
Prenatal onset short stature 17/17 0/8 17/25
Dysmorphology
Triangular face 4/17 0/8 4/25
Broad nasal bridge 10/17 3/8 13/25
Bulbous tip of nose 10/17 2/8 12/25
Hair abnormalities 5/17 1/8 6/25
Multiple lentigines 14/17 3/8 17/25
High pitched voice 5/17 0/8 5/25
Normal intelligence 16/16 8/8 24/24
Spondyloepiphyseal dysplasia 17/17 8/8 25/25
Cellular immune deficiency 17/17 6/6 23/23
Renal




Other Corneal opacities (3), microdontia (1), coarse, low
voice (1), autoimmune haemolytic anaemia with
thrombocytopenia (2), autoimmune enteropathy
(1), mesangioproliferative glomerulonephritis (1),
ventricular septal defect (1)
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After end stage renal failure, biopsy speci-
mens are described as focal segmental
glomerulosclerosis with foci of tubular atrophy
and fibrosis of the interstitium (case 18) and
necropsy studies mention diVuse and global
sclerosis, atrophic or wide tubuli, fibrotic inter-
stitium, and thickened and hyalinised arterioles
(cases 1 and 24).
The increased urinary excretion of
chondroitin-6-sulphfate first reported by
Schimke et al2 was not present in any of the
other patients with immuno-osseous dysplasia
except for the one reported here and two cases
described as having slightly increased urinary
mucopolysaccharide levels, composed of
chondroitin-6-sulphate and chondroitin-4-
sulphate (case 14 7). It also disappeared in the
proband described by Schimke as he became
older.1
The aetiology and physiopathology of
Schimke immuno-osseous dysplasia remain
unknown. Although it is likely that a primary
immune disease may aVect the kidney, it is
more diYcult to accept that it may interfere
with bone growth starting before birth as hap-
pens in the severe spectrum of the disease.
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